Literature DB >> 3403783

The use of continuous arteriovenous hemodialysis in the management of patients with oliguria associated with multiple organ failure.

E Barzilay, N Weksler, D Kessler, J Prego.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3403783     DOI： 10.1007/bf00262910

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

1.  Continuous arteriovenous hemodialysis: a new modality for treatment of acute renal failure.

Authors:  R Geronemus; N Schneider
Journal:  Trans Am Soc Artif Intern Organs       Date:  1984

2.  Prognosis in acute organ-system failure.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman
Journal:  Ann Surg       Date:  1985-12       Impact factor: 12.969

3.  Management of anuric intensive-care patients with arteriovenous hemofiltration.

Authors:  P Kramer; G Kaufhold; H J Gröne; W Wigger; J Rieger; D Matthaei; T Stokke; H Burchardi; F Scheler
Journal:  Int J Artif Organs       Date:  1980-07       Impact factor: 1.595

4.  Sequential hemofiltration in nonoliguric high capillary permeability pulmonary edema of severe sepsis: preliminary report.

Authors:  L Gotloib; E Barzilay; A Shustak; A Lev
Journal:  Crit Care Med       Date:  1984-11       Impact factor: 7.598

5.  Continuous arteriovenous hemofiltration. A report of six months' experience.

Authors:  A A Kaplan; R E Longnecker; V W Folkert
Journal:  Ann Intern Med       Date:  1984-03       Impact factor: 25.391

6.  Multiple-organ failure. Generalized autodestructive inflammation?

Authors:  R J Goris; T P te Boekhorst; J K Nuytinck; J S Gimbrère
Journal:  Arch Surg       Date:  1985-10
  6 in total
  2 in total

1.  More on acute renal failure in the intensive care unit.

Authors:  E Barzilay; G Berlot; D Kessler; D Geber
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

2.  Mitochondrial Haplogroup and the Risk of Acute Kidney Injury Following Cardiac Bypass Surgery.

Authors:  Nigel S Kanagasundaram; Simon V Baudouin; Sarah Rowling; Mahesh Prabhu; John H Dark; Timothy H J Goodship; Patrick F Chinnery; Gavin Hudson
Journal:  Sci Rep       Date:  2019-02-19       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.